Jakavi Ruxolitinib 10 mg Tablets – JAK1 & JAK2 Inhibitor Medicine
Jakavi Ruxolitinib 10 mg Tablets are a prescription oral medicine used to manage serious blood and immune system disorders. Ruxolitinib works by blocking the JAK1 and JAK2 enzymes, which play a key role in abnormal immune responses and uncontrolled blood cell production. By targeting these pathways, Jakavi helps reduce inflammation, improve blood cell balance, and relieve disease-related symptoms.
How Jakavi Works
Jakavi inhibits the JAK-STAT signaling pathway, which is responsible for transmitting inflammatory and immune signals inside the body. In certain diseases, this pathway becomes overactive and leads to excessive inflammation and abnormal blood cell growth. By blocking JAK1 and JAK2, Jakavi helps restore immune balance and improves overall disease control.
Medical Uses
Jakavi is approved for the treatment of:
-
Myelofibrosis – a bone marrow disorder that affects normal blood cell production
-
Polycythemia Vera – a condition where the body produces too many red blood cells
-
Graft-Versus-Host Disease (GVHD) – a serious immune reaction after stem cell or bone marrow transplant
These conditions require careful immune control, and Jakavi is used when other treatments are not effective or not tolerated.
Key Benefits
-
Targeted JAK1 & JAK2 inhibition
-
Helps regulate abnormal immune activity
-
Supports healthy blood cell production
-
Reduces symptoms such as fatigue and spleen enlargement
-
Oral tablet for convenient daily use
Dosage & Administration
Jakavi 10 mg tablets are taken by mouth as prescribed by a healthcare professional. The exact dose depends on the patient’s condition, blood test results, and response to treatment.
Safety Information
Jakavi is a prescription-only medicine and should be used under medical supervision. Regular blood tests are often required during treatment. It is not intended for cosmetic or skin repigmentation use, including vitiligo, in tablet form.
Product Category
Hematology Medicine
Immunology Therapy
JAK Inhibitor Drugs
Disclaimer
This content is for informational purposes only and does not replace professional medical advice. Jakavi (Ruxolitinib) should be used only under the supervision of a qualified healthcare specialist.
